Development and progression of psoriasif orm dermatitis and systemic lesions in the flaky skin (fsn) mouse mutant

Pathobiology

Volumn 65, Issue 5, 1997, Pages 271-286

  Sundberg, John P ^a   France, Malcolm ^a,c   Boggess, Dawnalyn ^a   Sundberg, Beth A ^a   Jenson, Bennett ^b   Beamer, Wesley G ^a   Shultz, Leonard D ^a  

^a JACKSON LABORATORY   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Animal model; Flaky skin mouse mutation; Forestomach papillomatosis; Gastric dysplasia; Glomerulonephritis; Mast cells; Proliferative skin disease; Psoriasis

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; COMPLEMENT DEPOSITION; CONTROLLED STUDY; DERMATITIS; EPIDERMIS HYPERPLASIA; ERYTHROPOIESIS; FORESTOMACH; GLOMERULOPATHY; IMMUNE COMPLEX DEPOSITION; INFLAMMATORY CELL; INTESTINE CELL; LIVER FIBROSIS; LYMPHADENITIS; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MAST CELL; MOUSE; MOUSE MUTANT; NEOVASCULARIZATION (PATHOLOGY); NEUTROPHIL; NONHUMAN; PAPILLOMATOSIS; PRIORITY JOURNAL; PSORIASIS; SKIN INFLAMMATION; SPLENOMEGALY; TESTIS ATROPHY;

AGING; ANIMALS; CECUM; DISEASE MODELS, ANIMAL; FEMALE; IMMUNOHISTOCHEMISTRY; KIDNEY GLOMERULUS; LIVER; MALE; MICE; MICE, INBRED BALB C; MICE, MUTANT STRAINS; PSORIASIS; SKIN; SPLEEN; STOMACH; TESTIS;

ANIMALIA;

EID: 0030785132     PISSN: 10152008     EISSN: 14230291     Source Type: Journal    
DOI: 10.1159/000164138     Document Type: Article

References (63)

1. Mason KV, Halliwcll RHW. McDougal BJ: Characterization of lichenoid-psoriasiform dermatosis of Springer Spaniels. J Am Vet Med Assoc 1986:189:897-901.
2. Gross TL. Halliwcll RE, McDougal BJ. Roscncranlz WS: Psoriasiform lichenoid dermatitis in the Springer Spaniel. Vet Pathol 1986:23: 76-78.
3. Lowe NJ. Breeding J, Kean C, Cohn ML: Psoriasiform dermatoses in a rhesus monkey. J Invest Dermatol 1981:76:141-143.
4. Jayo JM. Jayo MJ. Zanolli MD. Benedict L: Psoriasis in a cynomologus monkey. Lab Anim Sci 1988:38:512.
5. Dunstan RVV. Rosser ER: Does a condition like human pityriasis rosea occur in pigs? Am J Dermatopathol 1986:8:86-89.
6. Dunstan RW. Rosser EJ: Newly recognized and emerginggenodcrmatoses in domestic animals. Curr Prob Dermatol 1987:17:216-235.
7. Lowe NJ. Stoughton RB: Essential fatty acid deficient hairless mice: Model of chronic epidermal hyperproliferation. Br J Dermatol 1977;96:115-162.
8. Wolf R, Shechter H. Brenner S: Induction of psoriasiform changes in guinea pig skin by propranolol. Int J Dermatol 1994:33:811-814.
9. Rccht B. Fraki JE: Research models for psoriasis. Cutis 1985;36:203-204.
10. Abel EA. DiCicco LM: Orenbcrg EK. Fraki JE. Farber FM: Drugs in exacerbation of psoriasis. J Am Acad Dermatol 1986:15:1007-1022.
11. Gaylarde PM. Brock AP. Sarkany I: Psoriasiform changes in guinea-pig skin from propranolol. Clin Exp Dermatol 1978:3:157-160.
12. Tuzun B. Tuzun Y. Gurel N, Tuzuner N, Altug N, Buvukdevrim S: Psoriasis-like lesions in guinea pigs receiving propranolol. Int J Dermatol 1993:32:133-134.
13. Schon MP. Dctmar M. Parker CM: Murine psoriasis-like disorder induced by naive CD4+ T cells. Nat Med 1997:3:183-188.
14. Femandez-Salguero PM. Ward JM. Sundberg JP. Gonzalez FJ: Cardiovascular, skin, and large bowel lesions in aging Ahr knockout mice. Vet Pathol, in press.
15. Hammer RE. Maika SD, Richardson JA. Tang J-P, Taurog JD: Spontaneous inflammatory disease in transgenic rats expressing HI.A-B27 and human B2m: An animal model of HLA-B27-associated human disorders. Cell 1990:63: 1099-1112.
16. Leonard JM. Abramczuk JW. Pczcn DS, Rutledge R. Belche JH. Hakim F. Shearer G. Lam-perth L. Travis W. Fredrickson T. Notkins AL, Marlin MA: Development of disease and virus recovery in transgenic mice containing HIV proviral DNA. Science 1988:242:1665-1670.
17. Wilson JB. Weinberg W. Johnson R. Yuspa S. Levine AJ: Expression of the BNLF-1 oncogene of Epstein-Barr virus in the skin of transgenic mice induces hyperplasia and aberrant expression of keratin 6. Cell 1990:61:1315-1327.
18. Bullard DC. Scharffetter-Kochanek K, McArthur MJ. Chosay JG. McBride ME. Montgomery CA. Beaudet AL: A polygenic mouse model of psoriasiform skin disease in CD 18-deficient mice. Proc Natl Acad Sci USA 1996:93:2116-2121.
19. Blessing M. Schirmachcr P. Kaiser S: Overexpression of bone morphogenetic protein-6 (BMP-6) in the epidermis of transgenic mice: Inhibition or stimulation of proliferation depending on the pattern of transgene expression and formation of psoriastic lesions. J Cell Biol 1996:135:227-239.
20. Klcmcnt JF. Rice NR. Car BD. Abbondanzo SJ. Powers GD, Bhatl H. Chen C-H. Rosen CA. Stewart CL: IkBa deficiency results in a sustained NF-kB response and severe widespread dermatitis in mice. Mol Cell Biol 1996: 16:2341-2349.
21. Carroll JM, Romero MR. Watt IM: Suprabas-al integrin expression in the epidermis of transgenic mice results in developmental defects and a phenotype resembling psoriasis. Cell 1995;83:957-968.
22. Groves RW, Mizutani H, Kieffer JD. Kupper TS: Inflammatory skin disease in transgenic mice that express high levels of interleukin la in basal epidermis. Proc Natl Acad Sci USA 1995:92:11874-11878.
23. Krueger GG, Chambers DA, Shelby J: Involved and uninvolved skin from psoriatic subjects: Are they equally diseased? Assessment by skin transplanted to congenitally athymic (nude) mice. J Clin Invest 1981:81:1548-1557.
24. Krueger G. Manning DD. Malouf J, Ogden B: Long-term maintenance of psoriatic human skin on congenitallv athymic (nude) mice. J Invest Dermatol 1975:64:307-312.
25. Haftek M. Ortonnc J-P. Staquel M-J. Viac J. TTuvolet J: Normal and psoriatic human skin grafts on 'nude' mice: morphological and immunological studies. J Invest Dermatol 1981; 76:48-52.
26. Nickolol TBJ. Kunkel SL. Burdick M. Stricter RM: Severe combined immunodeficiency mouse and human psoriatic skin chimeras. Validation of a new animal model. Am J Pathol 1995:146:580-588.
27. Powlcs AV. Brent L, Baker B, Valdimarsson H, Walker M. Fry L: Transplantation of psoriatic skin on the nude athymic mice docs not maintain features of psoriasis. J Invest Dermatol 1989:93:306.
28. Sundberg JP. Beamcr WG, Shultz LD. Dunstan RW: Inherited mouse mutations as models of human adnexal, comifieation. and papulosquamous dermatoses. J Invest Dermatol 1990: 95:62s-63s.
29. Sundberg JP, HogenESch H. King LE: Mouse models for scaly skin diseases: in Maibach HI (ed): Dermatologic Research Techniques. Boca Raton. CRC Press. 1995, pp 61-89.
30. Sundberg JP, King LE: Mouse mutations as animal models and biomedical tools for dermatological research. J Invest Dermatol 1996:106: 368-379.
31. Nannev LB, Sundberg JP. King LE: Increased epidermal growth factor receptor in fsn/fsn mice. Invest Dermatol 1996:106:1169-1174.
32. Beamer WG, Pelsu SC. Shultz LD, Sundberg JP. Barker JE: The flaky skin (fsn) mutation in mice: Map location and description of the anemia. Blood 1995:86:3220-3226.
33. Boggess D. Beamer WG. Shultz LD. Sundberg JP: Husbandry and phenotypic description of CBv-A-ft/t/J (flaky skin) mice. Jax Notes 1996: 465:2.
34. Booth C. Sundberg JP: Hemangiomas and he-mangiosarcomas in inbred laboratory mice. LabAnimSci 1995;45:497-502.
35. Bolon B. Calderwood-Mays MB: Conjugated avidin-peroxidasc as a stain for mast cell tumors. Vet Pathol 1988;25:523-525.
36. Bergstrcsscr PH. Tigelaar RE, Tharp MI: Conjugated avidin identifies cutaneous rodent and human mast cells. J Invest Dermatol 1984:83: 214-218.
37. Bussolati G. Gugliotta P: Nonspecific staining of mast cells by avidin-biotin-peroxidase complexes (ABC). J Histochcm Cytochem 1983:31: 1419-1421.
38. Sundberg JP. Cordy WR. King LE Jr: Alopecia areata in aging C3H/HeJ mice. J Invest Dermatol 1994:102:847-856.
39. Sundberg JP. Rourk M. Boggess D. Hogan ME. Roop DR. Bertolino A: Angora mouse mutation: Altered hair cycle, follicular dystrophy, phenotypic maintenance of skin grafts, and changes in keratin expression. Vet Pathol 1997; 34:171-179.
40. Morita K. Hogan ME. Nanncy LB. King LE. Manabe M, Sun T-T. Sundberg JP: Cutaneous ultrastructural features of the flaky skin (fin/ fin) mouse mutation. J Dermatol !995;22: 385-395.
41. Matsukura N, Shirota A. Asano G: Anatomy, histology, ultrastructure, rat; in Jones TC. Mohr U, Hunt RD (cds): Digestive System. Monographs on Pathology of Laboratory Animals. Heidelberg. Springer. 1985. pp 281-288.
42. Ghoshal NG. Bal HS: Comparative morphology of the stomach of some laboratory mammals. Lab Anim 1989:23:21-29.
43. Traupe H: The puzzling genetics of psoriasis. Clin Dermatol 1995;13:99-103.
44. Elder JT. Nair RP. Guo SW, Hcnseler T, Christophers E. Voorhees JJ: The genetics of psoriasis. Arch Dermatol 1994:130:216-224.
45. Tomforde J. Silverman A. Barnes R. Feman-dez-Vina MA. Young M. Morris L. Wucpper KD, Stastny P. Mcnter A. Bowcock A: Gene for familial psoriasis susceptibility mapped to the distal end of human chromosome 17q. Science 1994;264:1141-1144.
46. McKay LA. Leigh LM: Altered kcratinocyte growth and differentiation in psoriasis. Clin Dermatol 1995:13:105-114.
47. Roenigk HH. Maibach HI: Psoriasis. New York: Marcel Dekker, 1990.
48. Sundberg JP. Kcnty GA, Beamcr WG. Adkison DL: Forestomach papillomas in flaky skin and stcel-Dickie mutant mice. J Vet Diagn Invest 1992;4:312-317.
49. HogenEsch H. Gijbels M, OfTerman E. Hool't JV. Bckkum DV, Zurcher C: A spontaneous mutation characterized by chronic proliferative dermatitis in C57BL mice. Am J Pathol 1993;143:972-982.
50. Booth C. Sundberg JP: Spontaneous neoplasms in a large breeding colony of BALB/cJ and BALB/cByJ mice; in Mohr U. Dungworth DL. C’apcn CC. Carlton W. Sundberg JP. Ward J (eds): Pathobiology of the Aging Mouse. Washington. D.C. 1LSI Press. 1996. vol 1. pp 51-65.
51. Sundberg JP. Sundberg BA, Beamer WG: Comparison of chemical carcinogen skin tumor induction efficiency in inbred, mutant, and hybrid strains of mice: Morphologic variations of tumors and absence of a papillomarvi-rus co-carcinogen. Mol Carcinogen 1997: in press.
52. Lindelof B. Eklund G. Liden S. Stem RS: The prevalence of malignant tumors in patients with psoriasis. J Am Acad Dermatol 1990:22: 1056-1060.
53. Boehncke W-H: Psoriasis and bacterial superantigens- formal or causal correlation? Trends Microbiol 1996;4:485-489.
54. Eedy DJ, Burrows D, Bridges JM, Jones FGC: Clearance of severe psoriasis after allogeneic bone marrow transplantation. Br Med J 1990; 300:908.
55. Jowitt SN. Yin JAL: Psoriasis and bone marrow transplantation. BrMed J 1990:300:1398-1399.
56. Vallat VP. Gilleaudcau P. Battat L, Wolfe J. Nabeya R. Heftier N, Hodak E. Gottlieb AB: PU VA bath therapy strongly suppresses immunological and epidermal activation in psoriasis: A possible cellular basis for remittive therapy. J Exp Med 1994;180:283-296.
57. Gottlieb SL. Gillcaudeau P. Johnson R. Estes L, Woodworth TG, Gottlieb AB. Krueger JG: Response of psoriasis to a lymphocyte-selective toxin (DAB389IL-2) suggests a primary immune. but not kcratinocyte. pathogenic basis. Nature Med 1995;1:442-447.
58. Sundoerg JP. Boggess D. Sundberg BA, Beamer WG. Shultz LD: Epidermal dendritic cell populations in the flaky skin mutant mouse. Immunol Invest 1993;22:389-401.
59. Copeland NG. Gilbert DJ. Cho BC. Donovan PJ, Jenkins NA, Cosman D, Anderson D. Lyman SD, Williams DE: Mast cell growth factor maps near the steel locus on mouse chromosome 10 and is deleted in a number of steel alleles. Cell 1990;63:175-183.
60. Sundberg JP: Handbook of Mouse Mutations with Skin and Hair Abnormalities. Animal Models and Biomedical Tools. Boca Raton. CRC Press. 1994.
61. Shubert C, Schristophers E: Mast cells and macrophages in early relapsing psoriasis. Arch Dermatol Res 1985:277:352-358.
62. Goodfield M. Hull SM. Holland D. Roberts G. Wood E. Reid S, CunlifTc W: Investigations of the ‘active’ edge of plaque psoriasis. Vascular proliferation precedes changes in epidermal keratin. Br J Dermatol 1994;131:808-813.
63. Rothc MJ. Nowak M. Kerdel FA: The mast cell in health and disease. J Am Acad Dermatol 1990;23:615-624.